ERNA: Ernexa Therapeutics Inc. Stock

by  •  • Comments Off on ERNA: Ernexa Therapeutics Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 9.67
Enterprise Value ($M) 44.90
Book Value ($M) 1.70
Book Value / Share 0.03
Price / Book 5.68
NCAV ($M) -1.22
NCAV / Share -0.02
Price / NCAV -7.95

Profitability (mra)
Return on Invested Capital (ROIC) -1.13
Return on Assets (ROA) -0.90
Return on Equity (ROE) n/a

Liquidity (mrq)
Quick Ratio 0.80
Current Ratio 0.80

Balance Sheet (mrq) ($M)
Current Assets 2.35
Assets 5.27
Liabilities 3.57
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.58
Operating Income -17.25
Net Income -44.54
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -15.84
Cash from Investing -0.36
Cash from Financing 6.26

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
04-04 13D/A Cherington Charles 32.80 22.78
02-14 13G/A Halpern John D 9.99
02-14 13G/A Singer Nicholas Jason 4.92 327.16
02-12 13G/A Iaf, Llc 5.22 364.36
01-28 13G/A Freebird Partners LP 9.99 387.59

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-03-12 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K
2024-11-12 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-08-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-05-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 or ☐ TRANSITION REPOR

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-04-21 18,583 44,758 41.52
2025-04-17 22,027 84,443 26.09
2025-04-16 5,925 80,281 7.38

(click for more detail)

Similar Companies
ENVB – Enveric Biosciences, Inc. EPIX – ESSA Pharma Inc.
EQ – Equillium, Inc. ESLA – Estrella Immunopharma, Inc.
EVOK – Evoke Pharma, Inc.


Financial data and stock pages provided by
Fintel.io